Placeholder image of an Avatar

Chris Shields

Chief Executive Officer

Chris Shields is a dedicated healthcare technology executive who brings over 30 years of experience to Reliq. During his career he has held progressively senior roles at multi-billion dollar multinational companies including Millipore (later acquired by Merck) and Saint Gobain, and at technology start-ups including Natrix Separations (acquired by Millipore) and Finetex. Chris is based in Boston, MA. He holds a BSc in Chemical Engineering from the University of Massachusetts Lowell and an MBA specializing in Finance from Babson College in Wellesley, MA.